Literature DB >> 19307124

Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives.

Bixue Xu1, Zhengming Huang, Changxiao Liu, Zegui Cai, Weidong Pan, Peixue Cao, Xiaojiang Hao, Guangyi Liang.   

Abstract

A series of derivatives of Matijing-Su (MTS, N-(N-benzoyl-L-phenylalanyl)-O-acetyl-L-phenylalanol) was synthesized and evaluated for their anti-hepatitis B virus (HBV) activities in 2.2.15 cells. The IC(50) of compounds 9c (1.40 microM), 9g (2.33 microM) and 9n (2.36 microM), etc. and the selective index of 9n (45.93) of the inhibition on the replication of HBV DNA were higher than those of the positive control lamivudine [41.59, (IC(50): 82.42 microM)]. Compounds 11d, 12a and 12e also exhibited significant anti-HBV activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307124     DOI: 10.1016/j.bmc.2009.03.003

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

Review 1.  Discovery and development of anti-HBV agents and their resistance.

Authors:  Kyun-Hwan Kim; Nam Doo Kim; Baik-Lin Seong
Journal:  Molecules       Date:  2010-08-27       Impact factor: 4.411

Review 2.  Natural Products: Review for Their Effects of Anti-HBV.

Authors:  Xuqiang Liu; Changyang Ma; Zhenhua Liu; Wenyi Kang
Journal:  Biomed Res Int       Date:  2020-12-09       Impact factor: 3.411

Review 3.  Dichondra repens J.R.Forst. and G.Forst.: A Review of Its Traditional Uses, Chemistry, Pharmacology, Toxicology and Applications.

Authors:  Qi Yao; Ying Wang; Zhiyu Dong; Chencen Lai; Botao Chang; Qiuju Gong; Shuaijun Ren; Dongxue Sun; Jie Lu; Ying Gao
Journal:  Front Pharmacol       Date:  2021-02-08       Impact factor: 5.810

4.  A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9.

Authors:  Lanlan Li; Mingfei Yang; Jia Yu; Sha Cheng; Mashaal Ahmad; Caihong Wu; Xinwei Wan; Bixue Xu; Yaacov Ben-David; Heng Luo
Journal:  Int J Mol Sci       Date:  2022-09-18       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.